RENE
Overvalued by 103.7% based on the discounted cash flow analysis.
Market cap | $247.99 Million |
---|---|
Enterprise Value | $254.33 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.41 |
Beta | -0.02 |
Outstanding Shares | 21,620,561 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 28.66 |
---|---|
PEG | 51.3 |
Price to Sales | - |
Price to Book Ratio | 5.96 |
Enterprise Value to Revenue | - |
Enterprise Value to EBIT | -119.61 |
Enterprise Value to Net Income | 26 |
Total Debt to Enterprise | 0.03 |
Debt to Equity | 0.1 |
No data
No data